Encephalitis Lethargica: The Mysterious Sleeping Sickness

Encephalitis lethargica is a mysterious inflammatory brain disease that swept across the world between roughly 1916 and the late 1920s, leaving an estimated million or more people trapped in states ranging from profound sleepiness to rigid, statue-like immobility. Despite a century of investigation, no one has definitively identified what causes it. The disease earned the nickname “sleeping sickness” because of the deep, prolonged drowsiness many patients experienced, but that label undersells the staggering range of neurological and psychiatric havoc it could produce. Sporadic cases still appear today, and the condition’s relationship to influenza, autoimmunity, and even COVID-19 remains a live area of research.

What Happened During the Epidemic

The first recognized cases appeared in Vienna in the winter of 1916–1917, described by the neurologist Constantin von Economo. Over the next decade, waves of the illness spread across Europe, North America, and beyond. Estimates of the total number affected vary widely because diagnostic criteria were loose and record-keeping uneven, but the epidemic is generally thought to have killed hundreds of thousands and left many more permanently disabled. By the early 1930s, new acute cases had become rare, though the chronic aftereffects were only beginning to show themselves in survivors.

The timing overlapped with the 1918 influenza pandemic, a coincidence that shaped how doctors and the public thought about the disease for decades. That overlap also created a scientific puzzle that still hasn’t been cleanly resolved, as we’ll see below.

Acute Symptoms and How Wildly They Varied

One of the most unsettling features of encephalitis lethargica was how differently it could present from one patient to the next. During the acute phase, people typically experienced excessive sleepiness, eye-movement problems, fever, and movement disorders, but virtually any neurological symptom could appear, sometimes shifting from day to day or even hour to hour.¹ Some patients slept for days or weeks. Others developed the opposite problem and could not sleep at all. Still others became catatonic, frozen in odd postures with their eyes wide open.

A recent large-scale review of historical case records put numbers on how common each symptom cluster was. Motor problems appeared in about 98% of cases, cranial nerve findings in 91%, eye-related features in 77%, sleep disorders in 66%, gastrointestinal or nutritional problems in 62%, speech disorders in 61%, and psychiatric features in roughly 54%.² The breadth of those numbers explains why the disease was so hard to pin down clinically. A patient presenting with drowsiness and double vision looked nothing like a patient presenting with mania and involuntary movements, yet both could have the same underlying condition.

Oculogyric Crises and Other Distinctive Motor Signs

Among the more striking symptoms was a phenomenon called an oculogyric crisis: the eyes would roll involuntarily upward and lock in that position, sometimes for hours. Before encephalitis lethargica, this symptom was virtually unknown. It became one of the hallmarks of the disease and was later seen in survivors who developed chronic post-encephalitic syndromes.³ The crises could be accompanied by forced thinking, obsessive thoughts, or emotional disturbance, blurring the line between movement disorder and psychiatric episode.

Other motor features included rigidity, tremor, and slowness of movement that closely resembled Parkinson’s disease. Some patients developed these signs acutely; others appeared to recover from the initial illness only to slide into parkinsonism months or years later. That delayed progression became one of the defining tragedies of the epidemic.

The Psychiatric Side

Encephalitis lethargica didn’t just damage movement and sleep circuits. It could fundamentally alter personality and behavior. Some patients underwent severe personality changes and began engaging in behaviors that would previously have been completely foreign to them. Historical records describe cases of kleptomania, loss of moral reasoning, and sudden unprovoked aggression, including one patient who threw knives at others on the ward. Obsessive-compulsive symptoms also appeared: one patient could not stop polishing shoes or beating eggs despite desperately wanting to stop. Suicidal ideation and completed suicides were noted as well.⁴

The occurrence of mood disorders, obsessive-compulsive behavior, and slowed thinking in patients with clear brain inflammation drew early twentieth-century attention to the organic basis of mental illness.⁵ Before encephalitis lethargica, psychiatry and neurology were more sharply separated. The epidemic helped demonstrate that damage to specific brain structures could produce what had been considered purely “mental” conditions, a lesson that still resonates in how we understand neuropsychiatric disease.

Children Were Hit Especially Hard

Adults received most of the clinical attention, but children who contracted encephalitis lethargica often suffered some of the most devastating behavioral consequences. Roughly a third of affected children underwent a rapid transformation from normal behavior to delinquency, frequently severe enough to require institutionalization. The behavioral changes triggered by the disease have been described as unlike anything produced by any other neurological condition, with the possible exception of traumatic brain injury.⁶

These were children who, by all accounts, had been well-adjusted before getting sick. Afterward, some became violent, impulsive, or unable to follow social rules. The phenomenon created a wave of institutionalizations in the 1920s and prompted early debates about whether criminal behavior in certain young people might have a neurological origin. It was an uncomfortable question then, and the fact that a brain infection could strip away behavioral control in previously healthy children remains a sobering reminder of how tightly personality is tied to brain structure.

What the Disease Taught Us About Sleep

One of the lasting scientific contributions of the encephalitis lethargica epidemic came not from solving the disease itself but from what it revealed about how the brain regulates sleep. Von Economo noticed that patients who were excessively sleepy had damage concentrated in a different part of the brain than patients who couldn’t sleep. By studying post-mortem tissue, he deduced the existence of distinct brain centers for sleep and wakefulness.⁷

Specifically, he identified the front part of the hypothalamus as a sleep-promoting region and the rear part as a wakefulness center.⁸ This was a remarkable insight for the early 1900s, and modern sleep neuroscience has broadly confirmed it. The ventrolateral preoptic area (the “sleep switch” in the front hypothalamus) and the tuberomammillary nucleus and orexin neurons (wakefulness-promoting cells in the rear hypothalamus) correspond closely to what von Economo proposed from clinical observation alone. In a sense, a catastrophic epidemic handed neuroscience a natural experiment that jumpstarted our understanding of one of biology’s most basic functions.

Post-Encephalitic Parkinsonism

The chronic aftermath of encephalitis lethargica was, for many survivors, worse than the acute illness. Years or even decades after apparent recovery, large numbers of patients developed a progressive parkinsonian syndrome: rigidity, tremor, extreme slowness of movement, and in severe cases a frozen, trance-like state in which they were conscious but essentially unable to move or speak. These patients were the subjects of Oliver Sacks’s famous 1973 book Awakenings, in which he described administering the drug L-DOPA to post-encephalitic patients who had been institutionalized for decades.

Post-encephalitic parkinsonism looks similar to typical Parkinson’s disease on the surface, but under a microscope the pathology is different. The brain damage in post-encephalitic parkinsonism involves widespread neurofibrillary tangles composed of tau protein, with neuronal loss concentrated in subcortical and brainstem areas including the substantia nigra. Critically, the Lewy bodies and alpha-synuclein deposits that define typical Parkinson’s disease are completely absent.⁹ This means post-encephalitic parkinsonism is technically a tauopathy, placing it in the same broad protein-pathology family as some forms of frontotemporal dementia rather than conventional Parkinson’s. The distinction matters because it tells us that damage to the substantia nigra can produce parkinsonism through more than one molecular route.

The substantia nigra appears repeatedly in encephalitis lethargica research. One pediatric case report documented a child with bilateral substantia nigra lesions visible on brain imaging during the acute illness.¹⁰ That the same structure keeps showing up in acute and chronic phases alike suggests it is a primary target of whatever process drives the disease.

Was Influenza the Cause?

Because encephalitis lethargica emerged around the same time as the catastrophic 1918 flu pandemic, it was natural to suspect a connection. The relationship between the two was hotly debated during the 1920s and has never been fully settled.¹¹ The circumstantial case seems compelling: two massive neurological and respiratory epidemics running in parallel. But the closer researchers looked, the weaker the link became.

Epidemiological analyses have generally suggested the two diseases were coincidental rather than causally linked. Starting in the 1970s, researchers began testing archived brain tissue from encephalitis lethargica patients for influenza virus, and the results were consistently negative. One study prepared RNA from 29 autopsy tissue blocks from five acute cases and found no influenza genetic material in any of them.¹² Another group used a different technique to look for influenza genes in brain samples from the 1916–1920 outbreak and likewise came up empty, concluding either that influenza was not the causative agent or that the virus had a “hit-and-run” mechanism and was no longer present at the time of death.¹³

A critical review of the entire body of evidence concluded that while the experimental studies have real technical limitations, including the extreme scarcity and age of available tissue, there is still little direct evidence supporting influenza as the cause. The case against influenza may be less decisive than many researchers currently assume, but the positive case for it is thin.¹⁴ The honest answer, frustrating as it is, remains genuinely uncertain.

The Autoimmune Hypothesis

If the virus itself isn’t directly invading the brain, a plausible alternative is that the immune system is. Beginning in the early 2000s, researchers proposed that encephalitis lethargica might be a post-infectious autoimmune disorder, similar in concept to Sydenham’s chorea, the movement disorder that sometimes follows streptococcal throat infections in children.

A landmark study examined 20 modern patients who met clinical criteria for encephalitis lethargica. Anti-streptolysin-O titers, a marker of recent streptococcal infection, were elevated in 65% of them. More strikingly, 95% had autoantibodies that reacted against proteins in the basal ganglia, the deep brain structures that control movement and aspects of behavior. By comparison, those antibodies were found in only 2 to 4% of healthy control subjects.¹⁵ The finding suggested that at least some cases of encephalitis lethargica involve the body’s immune system mistakenly attacking its own brain tissue after an infection, possibly streptococcal, triggers the process.

This doesn’t fully explain the original epidemic, which would require an autoimmune trigger affecting vast numbers of people across continents. But it does provide a working framework for understanding why sporadic cases continue to appear and, more practically, why some patients respond to treatments that dampen the immune system.

Sporadic Cases in the Modern Era

Encephalitis lethargica did not vanish after the 1920s. It became extremely rare, but individual cases matching the classical description have continued to surface. A case series of eight contemporary patients, ranging in age from 2 to 28, found that all had encephalopathy, sleep disturbances, and movement abnormalities. Brain imaging showed structural abnormalities in seven of the eight, and anti-basal-ganglia antibodies were present in four of the seven tested. None of the patients in this particular series died, and several responded to immune-modulating treatments.¹⁶

Post-encephalitic parkinsonism has also continued to appear on a case-by-case basis. A clinical review identified patients presenting in recent decades whose illness conformed to the diagnostic criteria for encephalitis lethargica, reinforcing that the condition is not purely historical.¹⁷ The numbers are tiny compared with the epidemic era, but each case demonstrates that whatever biological process underlies encephalitis lethargica has not disappeared from the human population.

Diagnostic Confusion With Anti-NMDA Receptor Encephalitis

One complication in recognizing modern encephalitis lethargica is that it overlaps symptomatically with another autoimmune brain disease identified only in the 2000s: anti-NMDA receptor encephalitis. Both conditions can produce psychiatric symptoms, movement disorders, sleep disturbance, and altered consciousness, especially in young patients. In at least two published cases, patients initially diagnosed with encephalitis lethargica were later found to have anti-NMDA receptor antibodies, prompting a revised diagnosis with different treatment implications.¹⁸

A study of 20 pediatric patients with a clinical picture consistent with encephalitis lethargica found that half tested positive for anti-NMDA receptor antibodies. The antibody-positive children tended to have involuntary movements, agitation, seizures, and insomnia, while the antibody-negative children were more likely to have parkinsonism and excessive sleepiness. The researchers concluded that the movement-disorder-dominant form of pediatric encephalitis lethargica is effectively an NMDA receptor antibody encephalitis.¹⁹ This raises the possibility that some proportion of what has historically been called encephalitis lethargica, both in modern and epidemic-era cases, was actually a different autoimmune condition that we now have the tools to identify.

The practical upshot for clinicians is that any patient presenting with encephalitis-lethargica-like symptoms should be tested for anti-NMDA receptor antibodies and other recently identified autoimmune encephalitis markers. A positive result can change both treatment and prognosis.

COVID-19 and the Question of Recurrence

The arrival of COVID-19 inevitably drew comparisons to the 1918 influenza pandemic, and with those comparisons came questions about whether a new wave of encephalitis lethargica might follow. Some researchers have noted that certain neurological presentations associated with COVID-19 can resemble aspects of encephalitis lethargica.²⁰ The overlap is not specific enough to draw firm conclusions, but it has reignited interest in the disease and in the broader question of whether large-scale viral pandemics can trigger post-infectious neurological syndromes at epidemic levels.

A review examining the parallels between the 1918 pandemic and COVID-19 concluded that preparedness for pandemic-associated neurological complications is still insufficient, and called for clinical trials to determine how effective various public health measures would be in combination with vaccination and individual testing.²¹ Whether COVID-19 will produce its own encephalitis lethargica analog remains unclear. The neurological complications of COVID are real and varied, but nothing on the scale or with the clinical distinctiveness of the 1920s epidemic has materialized so far. That said, the original epidemic unfolded over more than a decade, and its chronic consequences took even longer to become apparent. It may simply be too early to know.

Why the Cause Still Eludes Us

A century of research and we still cannot point to a single pathogen, antibody, or mechanism and say definitively: this is what encephalitis lethargica is. Part of the difficulty is practical. The epidemic ended before modern virology, immunology, and neuroimaging existed. The archival brain tissue that survives is extremely old and scarce, making molecular analysis technically challenging and results hard to interpret. Part of the difficulty is conceptual. Encephalitis lethargica may not be a single disease at all. It could be a clinical syndrome, a common end-pathway that different triggers, including streptococcal infection, influenza, other viruses, or idiopathic autoimmune processes, all converge on by damaging the basal ganglia and related structures.

The autoimmune findings are the strongest lead currently available, but they don’t explain why the disease erupted on a massive scale in the 1910s and 1920s and then largely stopped. Streptococcal infections didn’t vanish after 1930. Something about the specific conditions of that era, whether a particular pathogen strain, a unique immunological landscape in a population ravaged by war and pandemic, or some other factor, created a perfect storm that hasn’t recurred at the same scale. Until we understand what lit the fuse, we can’t confidently predict whether it could happen again.